2024 annual financial data
Acumen Pharmaceuticals 2024 Operating margin
Acumen Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -114,017,000 USD and net income was -102,329,000 USD.
Operating cash flow was -86,215,000 USD.
Get free Acumen Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -114,017,000 USD
- Net income
- -102,329,000 USD
- Operating cash flow
- -86,215,000 USD